- Investing Ideas
- South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
SK Biopharmaceuticals
Market Cap: ₩6.2t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩79,500.00
7D
2.4%
1Y
-21.2%
Oscotec
Market Cap: ₩1.2t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩30,250.00
7D
0.3%
1Y
-5.6%
DongKoo Bio & Pharma
Market Cap: ₩100.2b
Manufactures and sells pharmaceuticals in South Korea.
A006620
₩3,705.00
7D
4.7%
1Y
-26.5%
JW Shinyak
Market Cap: ₩94.5b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,691.00
7D
-21.2%
1Y
10.1%